Obesity statistics

Infographic exploring the GLP-1 weight-loss economy, including Ozempic, Wegovy, Mounjaro, and Zepbound, covering market dominance, obesity trends, treatment effectiveness, costs, side effects, discontinuation rates, and key pharmaceutical players.

Health

The GLP-1 Economy: How Ozempic and Wegovy Changed the Business of Weight Loss

By Admin 3 weeks ago

For decades, the story of weight loss followed a very predictable pattern. Diets and lifestyle